Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophils.

Weeding E, Coit P, Yalavarthi S, Kaplan MJ, Knight JS, Sawalha AH.

Clin Immunol. 2018 Nov;196:110-116. doi: 10.1016/j.clim.2018.11.011. Epub 2018 Nov 22.

PMID:
30471352
2.

Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.

Knight JS, Mazza LF, Yalavarthi S, Sule G, Ali RA, Hodgin JB, Kanthi Y, Pinsky DJ.

Front Immunol. 2018 Jun 11;9:1322. doi: 10.3389/fimmu.2018.01322. eCollection 2018.

3.

Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.

Knight JS, Meng H, Coit P, Yalavarthi S, Sule G, Gandhi AA, Grenn RC, Mazza LF, Ali RA, Renauer P, Wren JD, Bockenstedt PL, Wang H, Eitzman DT, Sawalha AH.

JCI Insight. 2017 Sep 21;2(18). pii: 93897. doi: 10.1172/jci.insight.93897. [Epub ahead of print]

4.

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.

Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM.

Nat Commun. 2017 Feb 6;8:14252. doi: 10.1038/ncomms14252.

5.

Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al.

Yalavarthi S, Grenn RC, Knight JS.

Ann Rheum Dis. 2016 Dec;75(12):e82. doi: 10.1136/annrheumdis-2016-210529. Epub 2016 Oct 21. No abstract available.

6.

In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.

Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, Pinsky DJ, Henke PK, Knight JS.

Arthritis Rheumatol. 2017 Mar;69(3):655-667. doi: 10.1002/art.39938.

7.

Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis.

Ekholm L, Kahlenberg JM, Barbasso Helmers S, Tjärnlund A, Yalavarthi S, Zhao W, Seto N, Betteridge Z, Lundberg IE, Kaplan MJ.

Rheumatology (Oxford). 2016 Nov;55(11):1987-1992. Epub 2016 Aug 7.

8.

Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.

Grenn RC, Yalavarthi S, Gandhi AA, Kazzaz NM, Núñez-Álvarez C, Hernández-Ramírez D, Cabral AR, McCune WJ, Bockenstedt PL, Knight JS.

Ann Rheum Dis. 2017 Feb;76(2):450-457. doi: 10.1136/annrheumdis-2016-209442. Epub 2016 Jul 18.

9.

Reply.

Yalavarthi S, Knight JS.

Arthritis Rheumatol. 2016 May;68(5):1321-2. doi: 10.1002/art.39579. No abstract available.

10.

Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.

Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS.

Arthritis Rheumatol. 2015 Nov;67(11):2990-3003. doi: 10.1002/art.39247.

11.

Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.

Coit P, Yalavarthi S, Ognenovski M, Zhao W, Hasni S, Wren JD, Kaplan MJ, Sawalha AH.

J Autoimmun. 2015 Apr;58:59-66. doi: 10.1016/j.jaut.2015.01.004. Epub 2015 Jan 28.

12.

Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.

Zhou Y, Rideout WM 3rd, Bressel A, Yalavarthi S, Zi T, Potz D, Farlow S, Brodeur J, Monti A, Reddipalli S, Xiao Q, Bottega S, Feng B, Chiu MI, Bosenberg M, Heyer J.

PLoS One. 2014 Aug 27;9(8):e105886. doi: 10.1371/journal.pone.0105886. eCollection 2014.

13.

Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.

Knight JS, Subramanian V, O'Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ.

Ann Rheum Dis. 2015 Dec;74(12):2199-206. doi: 10.1136/annrheumdis-2014-205365. Epub 2014 Aug 7.

14.

Metachronous malignancies in head and neck region: report of two cases.

Yalavarthi S, Pamu PK, Thoondla M, Gupta S.

Indian J Pathol Microbiol. 2014 Apr-Jun;57(2):314-6. doi: 10.4103/0377-4929.134728.

15.

Hemodynamic, autonomic, and vascular effects of exposure to coarse particulate matter air pollution from a rural location.

Brook RD, Bard RL, Morishita M, Dvonch JT, Wang L, Yang HY, Spino C, Mukherjee B, Kaplan MJ, Yalavarthi S, Oral EA, Ajluni N, Sun Q, Brook JR, Harkema J, Rajagopalan S.

Environ Health Perspect. 2014 Jun;122(6):624-30. doi: 10.1289/ehp.1306595. Epub 2014 Mar 11.

16.

Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.

Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ.

Ann Rheum Dis. 2015 Jul;74(7):1417-24. doi: 10.1136/annrheumdis-2013-204837. Epub 2014 Feb 25.

17.

An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Kahlenberg JM, Yalavarthi S, Zhao W, Hodgin JB, Reed TJ, Tsuji NM, Kaplan MJ.

Arthritis Rheumatol. 2014 Jan;66(1):152-62. doi: 10.1002/art.38225.

18.

Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.

Knight JS, Luo W, O'Dell AA, Yalavarthi S, Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT, Kaplan MJ.

Circ Res. 2014 Mar 14;114(6):947-56. doi: 10.1161/CIRCRESAHA.114.303312. Epub 2014 Jan 14.

19.

Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, Liesveld J, Sanz I, Baechler E, Kaplan MJ, Anolik JH.

J Immunol. 2014 Feb 1;192(3):906-18. doi: 10.4049/jimmunol.1302112. Epub 2013 Dec 30.

20.

The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ.

J Am Heart Assoc. 2013 Nov 19;2(6):e000441. doi: 10.1161/JAHA.113.000441.

21.

Diagnostic dilemma in a malignant cutaneous adnexal tumor.

Yalavarthi S, Rangarao SP, Kumar SS, Supriya M.

Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):331-33. doi: 10.4103/0377-4929.120423. No abstract available.

22.

The effect of acute exposure to coarse particulate matter air pollution in a rural location on circulating endothelial progenitor cells: results from a randomized controlled study.

Brook RD, Bard RL, Kaplan MJ, Yalavarthi S, Morishita M, Dvonch JT, Wang L, Yang HY, Spino C, Mukherjee B, Oral EA, Sun Q, Brook JR, Harkema J, Rajagopalan S.

Inhal Toxicol. 2013 Aug;25(10):587-92. doi: 10.3109/08958378.2013.814733. Epub 2013 Aug 6.

23.

Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis.

Ranganathan P, Khalatbari S, Yalavarthi S, Marder W, Brook R, Kaplan MJ.

J Rheumatol. 2013 Sep;40(9):1529-34. doi: 10.3899/jrheum.130012. Epub 2013 Jul 1.

24.

Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.

Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ.

J Clin Invest. 2013 Jul;123(7):2981-93. doi: 10.1172/JCI67390. Epub 2013 Jun 3.

25.

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer.

Mohiuddin M, Paulus R, Mitchell E, Hanna N, Yuen A, Nichols R, Yalavarthi S, Hayostek C, Willett C.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):523-8. doi: 10.1016/j.ijrobp.2013.02.020. Epub 2013 Mar 29.

26.

NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.

Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ.

Sci Transl Med. 2013 Mar 27;5(178):178ra40. doi: 10.1126/scitranslmed.3005580.

27.

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ.

Ann Rheum Dis. 2011 Sep;70(9):1550-5. doi: 10.1136/ard.2010.148031. Epub 2011 Jul 4.

28.

Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ.

J Immunol. 2011 Jul 1;187(1):538-52. doi: 10.4049/jimmunol.1100450. Epub 2011 May 25.

29.

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.

Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT.

J Immunol. 2011 Jul 1;187(1):490-500. doi: 10.4049/jimmunol.1100123. Epub 2011 May 23.

30.

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, Huang P, Sawyer SK, Fuerth B, Faubert B, Kalliomäki T, Elia A, Luo X, Nadeem V, Bungard D, Yalavarthi S, Growney JD, Wakeham A, Moolani Y, Silvester J, Ten AY, Bakker W, Tsuchihara K, Berger SL, Hill RP, Jones RG, Tsao M, Robinson MO, Thompson CB, Pan G, Mak TW.

Genes Dev. 2011 May 15;25(10):1041-51. doi: 10.1101/gad.1987211.

31.

Determinants of vascular function in patients with chronic gout.

Brook RD, Yalavarthi S, Myles JD, Khalatbari S, Hench R, Lustig S, Marder W, Neidert A, Kaplan MJ.

J Clin Hypertens (Greenwich). 2011 Mar;13(3):178-88. doi: 10.1111/j.1751-7176.2010.00406.x. Epub 2010 Dec 22.

32.

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.

Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, McCune WJ, Kaplan MJ.

J Immunol. 2010 Mar 15;184(6):3284-97. doi: 10.4049/jimmunol.0902199. Epub 2010 Feb 17. Erratum in: J Immunol. 2010 Sep 15;185(6):3779.

33.

De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor model.

Watters JW, Cheng C, Majumder PK, Wang R, Yalavarthi S, Meeske C, Kong L, Sun W, Lin J, Heyer J, Ware C, Winter C, Reilly JF, Demuth T, Clark S, Chiu MI, Robinson MO, Kohl N, Kannan K.

Cancer Res. 2009 Dec 1;69(23):8949-57. doi: 10.1158/0008-5472.CAN-09-1544. Epub 2009 Nov 10.

34.

Design and dose distribution for rectal applicators for the high dose rate remote afterloading iridium-192 brachytherapy system.

Kennedy DK, Klonowski LM, Wade RF, Sanwalani SC, Yalavarthi SD.

Med Dosim. 1989 Sep;14(3):209-18.

PMID:
2604856
35.

Tolerance of the human spinal cord to high energy p(66)Be(49) neutrons.

Cohen L, Ten Haken RK, Mansell J, Yalavarthi SD, Hendrickson FR, Awschalom M.

Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):743-9.

PMID:
3980271

Supplemental Content

Loading ...
Support Center